Is Microsoft (MSFT) Quietly Redefining Its AI Moat Through Dedicated Energy Infrastructure Deals?

  • In June 2026, Chevron’s Energy Forge One subsidiary agreed a 20‑year power purchase deal to build the Kilby co‑located natural gas plant in West Texas, supplying about 2.67 gigawatts of dedicated electricity to a Microsoft‑operated AI data center starting from 2028.
  • Coupled with Microsoft’s newly operational Fairwater data center in Wisconsin, this long‑term Chevron partnership signals a direct push to secure bespoke power and supercomputing capacity for large‑scale AI workloads outside strained regional grids.
  • We’ll now examine how locking in dedicated 2.67‑gigawatt power capacity for Project Kilby could reshape Microsoft’s AI‑driven investment narrative.

The latest GPUs need a type of rare earth metal called Dysprosium and there are only 29 companies in the world exploring or producing it. Find the list for free.

Advertisement

Microsoft Investment Narrative Recap

To own Microsoft, you effectively need to believe its huge AI and cloud bet will translate into durable, profitable demand, not just spending. The Chevron Kilby power deal and the Fairwater supercomputing campus both speak directly to the biggest near term swing factor: whether Microsoft can secure enough capacity to serve AI workloads without letting CapEx overwhelm free cash flow. On balance, this news helps on the capacity side but does not remove the risk of underutilised infrastructure if AI demand disappoints.

Among recent announcements, the expanded KPMG partnership, rolling Microsoft 365 Copilot and Agent 365 out to more than 276,000 professionals, feels especially relevant. It shows how Microsoft is trying to turn all that secured power and compute into concrete enterprise usage and recurring AI revenue. For investors, these kinds of broad deployments matter as much as headline data center projects, because they help determine whether AI monetisation keeps pace with the infrastructure bill.

Yet even as Microsoft scales AI power and partnerships, investors should be aware of how quickly US$190 billion of planned 2026 CapEx could become a problem if...

Read the full narrative on Microsoft (it's free!)

Microsoft's narrative projects $510.7 billion revenue and $192.9 billion earnings by 2029.

Uncover how Microsoft's forecasts yield a $561.39 fair value, a 50% upside to its current price.

Exploring Other Perspectives

MSFT 1-Year Stock Price Chart
MSFT 1-Year Stock Price Chart

More bullish analysts were already assuming Microsoft could push revenue to about US$515 billion and earnings to roughly US$223 billion by 2029, so they see deals like Kilby as backing a much faster AI ramp than the consensus narrative. If you are weighing those higher expectations against the risk that huge 2026 CapEx ends up underused, it is worth recognising how far apart reasonable views can be and why fresh news like this could still shift both stories.

Explore 73 other fair value estimates on Microsoft - why the stock might be worth as much as 66% more than the current price!

Form Your Own Verdict

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

No Opportunity In Microsoft?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqGS:MSFT

Microsoft

Develops and supports software, services, devices, and solutions worldwide.

Very undervalued with outstanding track record and pays a dividend.

Advertisement

Weekly Picks

LO
Lou_Basenese
VTIX logo
Lou_Basenese on Virtuix Holdings ·

From a “Shark Tank” Snub to an Air Force “Yes”: Why Virtuix at $3.50 May Be the Market’s Most Mispriced AI Story

Fair Value:US$7.551.2% undervalued
4 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative
IN
Investingwilly
MA logo
Investingwilly on Mastercard ·

Mastercard: The Best Dividend Stock You're Ignoring

Fair Value:US$75034.9% undervalued
25 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative
TR
tripledub
INTU logo
tripledub on Intuit ·

A Wonderful Business at a Not-So-Wonderful Price

Fair Value:US$56053.9% undervalued
52 users have followed this narrative
2 users have commented on this narrative
28 users have liked this narrative
TA
Talos
HYFT logo
Talos on MindWalk Holdings ·

The Asymmetric TechBio Play: MindWalk Holdings and the Valuation Disconnect

Fair Value:US$8.2782.0% undervalued
17 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative

Updated Narratives

AN
AnimalDoctorKwon
RCKT logo
AnimalDoctorKwon on Rocket Pharmaceuticals ·

The Structural Disconnect Between Market Valuation and Operational Maturity

Fair Value:US$1066.5% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AN
AnimalDoctorKwon
AKBA logo
AnimalDoctorKwon on Akebia Therapeutics ·

Vafseo and the Future of Renal Anemia Treatment – Akebia’s Vision for a $5B Kidney Disease Portfolio

Fair Value:US$77.2998.6% undervalued
6 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AN
AnimalDoctorKwon
MBIO logo
AnimalDoctorKwon on Mustang Bio ·

A CAR-T Therapy Pipeline with Complete Remission (CR) Data Priced as a Negative Asset???

Fair Value:US$1.861.5% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7444.6% undervalued
67 users have followed this narrative
0 users have commented on this narrative
16 users have liked this narrative
HA
HarishPK
ADBE logo
HarishPK on Adobe ·

Adobe: A Probabilistic Case for Undervaluation

Fair Value:US$319.9638.3% undervalued
61 users have followed this narrative
9 users have commented on this narrative
18 users have liked this narrative
HE
HedgeY
ASTS logo
HedgeY on AST SpaceMobile ·

AST SpaceMobile: The Boldest Direct-to-Cell Bet in Public Markets

Fair Value:US$17057.1% undervalued
51 users have followed this narrative
0 users have commented on this narrative
13 users have liked this narrative